Best Assays for Natural Extracts in Discovery
Identify the best assays for natural extracts with a staged framework for triage, fractionation, validation, and development-ready decisions in research.
Author Archive for: GenBio Inc.
Entries by GenBio Inc.
Mapping Extract Activity to Compounds with Evidence
Mapping extract activity to compounds requires reproducible assays, guided fractionation, identification, and a clear path toward early candidate selection.
7 Top Early Discovery Risks to Address Early
Top early discovery risks can erode program value before candidate selection. Learn the evidence, controls, and planning needed to make informed decisions.
Compound Characterization Before Development
Compound characterization turns natural-product signals into reproducible evidence for candidate selection, intellectual property, and development planning
Are Natural Compounds Developable? The Evidence Test
Are natural compounds developable? Learn how rigorous fractionation, characterization, reproducibility, and planning determine early development potential.
Guide to Early Lead Optimization Decisions
This guide to early lead optimization outlines how evidence, reproducibility, developability, and regulatory planning inform early candidate decisions.
How to Isolate Bioactive Metabolites Reliably
Learn how to isolate bioactive metabolites through bioactivity-guided fractionation, analytical characterization, and disciplined candidate selection steps.
How to Validate Natural Product Hits Reliably
A disciplined framework to validate natural product hits through reproducibility, chemical characterization, orthogonal assays, and candidate decisions.
How Bioactive Compounds Become Candidates
Bioactive compounds require more than an assay signal. See how disciplined fractionation, characterization, and validation inform candidate selection plans.
Biotechnology Natural Products Investment Trends
Biotechnology natural products investment trends favor evidence-led platforms, reproducible data, and staged programs with credible development paths rigor.
